NPR logo

Experimental Drug Focuses On Alzheimer's 'Tangles'

  • Download
  • <iframe src="https://www.npr.org/player/embed/93158254/93158246" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript
Experimental Drug Focuses On Alzheimer's 'Tangles'

Research News

Experimental Drug Focuses On Alzheimer's 'Tangles'

Experimental Drug Focuses On Alzheimer's 'Tangles'

  • Download
  • <iframe src="https://www.npr.org/player/embed/93158254/93158246" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

An experimental drug that aims to unknot the "tangles" that characterize the brains of people with Alzheimer's has shown some promise. Guests discuss recent Alzheimer's findings and the search for new treatments, including statin drugs, often used to treat high cholesterol.

Guests:

Mary Haan, professor of epidemiology at the School of Public Health, University of Michigan

Ralph Nixon, vice chairman of the Alzheimer's Association's Medical and Scientific Advisory Council; professor of psychiatry and cell biology and director of the Silberstein Institute for Aging and Dementia at New York University